Organization Profile

You just read:

Daiichi Sankyo Submits Supplemental New Drug Application in Japan for LIXIANA® (Edoxaban Tosilate Hydrate) for New Indications

News provided by

Daiichi Sankyo Company, Limited

Dec 19, 2013, 07:05 ET